Inozyme pharma to present at the td cowen 45th annual health care conference

Boston, feb. 24, 2025 (globe newswire) -- inozyme pharma, inc. (nasdaq: inzy) (“the company” or “inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect bone health and blood vessel function, today announced that doug treco, ph.d., ceo and chairman of inozyme, will present at the td cowen 45th annual health care conference on monday, march 3, 2025, from 1:10-1:40pm et.
COWN Ratings Summary
COWN Quant Ranking